María Muñoz Caffarel

Ikerbasque Research Associate, Biogipuzkoa Health Research Institute

Ikerbasque Research Associate at the Oncology Area of Biogipuzkoa Health Research Institute and Hospital Donostia.

Research line:

Cancer cell signalling and therapeutics.

Junior Research Fellow in Wolfson College, Cambridge.

Previous research experience in cancer research in Spain (Universidad Complutense, CNIO, and IDIBELL), UK (University of Cambridge) and France (Institut Curie, Paris).

Doctor in Biochemistry and Molecular Biology (2008) from the Universidad Complutense (Madrid, Spain).

2024

Article / A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Breast Cancer Research

López-Velazco, J.I.; Manzano, S.; Otaño, M.; Elorriaga, K.; Bultó, N.; Herrero, J.; Lahuerta, A.; Segur, V.; Álvarez-López, I.; Caffarel, M.M.; Urruticoechea, A.

Article / Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR<sup>+</sup> breast cancer

Science Translational Medicine

Bacci, M.; Lorito, N.; Smiriglia, A.; Subbiani, A.; Bonechi, F.; Comito, G.; Morriset, L.; El Botty, R.; Benelli, M.; López-Velazco, J.I.; Caffarel, M.M.; Urruticoechea, A.; Sflomos, G.; Malorni, L.; Corsini, M.; Ippolito, L.; Giannoni, E.; Meattini, I.; Matafora, V.; Havas, K.; Bachi, A.; Chiarugi, P.; Marangoni, E.; Morandi, A.

Article / Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis

Science Advances

Bakhshandeh, S.; Heras, U.; Taïeb, H.M.; Varadarajan, A.R.; Lissek, S.M.; Hücker, S.M.; Lu, X.; Garske, D.S.; Young, S.A.E.; Abaurrea, A.; Caffarel, M.M.; Riestra, A.; Bragado, P.; Contzen, J.; Gossen, M.; Kirsch, S.; Warfsmann, J.; Honarnejad, K.; Klein, C.A.; Cipitria, A.

2023

Article / A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor positive breast cancer

medXriv

López-Velazco J, Manzano S, Otaño M, Elorriaga K, Bultó N, Lahuerta A, Martínez A, Segur V, Álvarez-López I, Caffarel MM and Urruticoechea A

Article / Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

Nature Communications

Tundidor, I.; Seijo-Vila, M.; Blasco-Benito, S.; Rubert-Hernández, M.; Adámez, S.; Andradas, C.; Manzano, S.; Álvarez-López, I.; Sarasqueta, C.; Villa-Morales, M.; González-Lois, C.; Ramírez-Medina, E.; Almoguera, B.; Sánchez-López, A.J.; Bindila, L.; Hamann, S.; Arnold, N.; Röcken, C.; Heras-Murillo, I.; Sancho, D.; Moreno-Bueno, G.; Caffarel, M.M.; Guzmán, M.; Sánchez, C.; Pérez-Gómez, E.

Article / Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature

Frontiers in Immunology

Serna, L.; Azcoaga, P.; Brahmachary, M.; Caffarel, M.M.; Braza, M.S.

Review / New perspectives in cancer immunotherapy: targeting IL-6 cytokine family

Journal for ImmunoTherapy of Cancer

Soler, M.F.; Abaurrea, A.; Azcoaga, P.; Araujo, A.M.; Caffarel, M.M.

2022

Chapter / Tratamiento médico neoadyuvante y adyuvante del cáncer de mama precoz: tumores luminales

Manual práctico de oncología. Cáncer de mama

Joanna I. López-Velazco, Francisco Jesús Fernández Ruiz, María M. Caffarel, Ander Urruticoechea Ribate

Article / Stromal Oncostatin M axis promotes breast cancer progression by reprogramming the tumor microenvironment

Journal of Clinical Investigation

A. M. Araujo, A. Abaurrea, P. Azcoaga, J. I. López-Velazco, R. Rezola; I. Osorio-Querejeta, F. Valdés-Mora, J. M. Flores, L. Jenkins,P. Fernandez-Nogueira, N. Ferrari, N. Martín-Martín, A. Tzankov, S. Eppenberger-Castori, I. Alvarez-Lopez, A.Urruticoechea, P. Bragado, N. Coleman, A. Carracedo, D. Gallego-Ortega, F. Calvo, C. M. Isacke, M. M. Caffarel*, C. H. Lawrie.*corresponding author

Article / Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

Journal of Clinical Investigation

Araujo, A.M.; Abaurrea, A.; Azcoaga, P.; López-Velazco, J.I.; Manzano, S.; Rodriguez, J.; Rezola, R.; Egia-Mendikute, L.; Valdés-Mora, F.; Flores, J.M.; Jenkins, L.; Pulido, L.; Osorio-Querejeta, I.; Fernández-Nogueira, P.; Ferrari, N.; Viera, C.; Martín-Martín, N.; Tzankov, A.; Eppenberger-Castori, S.; Alvarez-Lopez, I.; Urruticoechea, A.; Bragado, P.; Coleman, N.; Palazón, A.; Carracedo, A.; Gallego-Ortega, D.; Calvo, F.; Isacke, C.M.; Caffarel, M.M.; Lawrie, C.H.

Review / Microglia and metastases to the central nervous system: victim, ravager, or something else?

Journal of Experimental and Clinical Cancer Research

Caffarel, M.M.; Braza, M.S.

2021

Article / Therapeutic pretargeting with ultra-small nanoparticles: Boron carbon dots as drug candidates for boron neutron capture therapy

J. Mater. Chem. B

I. V. J. Feiner, K. R. Pulagam, C. Simó, K. Zamacola, V. Gómez-Vallejo, N. Herrero-Álvarez, U. Cossío, Z. Baz, M. M. Caffarel, C. H. Lawrie, D. J. Vugts, L. Rejc, J. Llop.

Article / Heparin length in the coating of extremely small iron oxide nanoparticles regulates in vivo theranostic applications

Nanoscale

H. Groult, S. Carregal-Romero, D. Castejón, M. Azkargorta, A.B. Miguel Coello, K. R. Pulagam, V. Gómez-Vallejo, R. Cousin, M.M. Caffarel, C. H. Lawrie, J. Llop, J-M. Piot, F. Elortza, T. Maugard, J. Ruiz-Cabello, I. Fruitier-Arnaudin.

Article / Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer

Proc Natl Acad Sci U S A

S. Blasco-Benito, E. Moreno, M. Seijo-Vila, I. Tundidor, C. Andradas, M. M. Caffarel, M. Caro-Villalobos, L. Urigüen, R. Diez-Alarcia, G. Moreno-Bueno, L. Hernández, L. Manso, P. Homar-Ruano, P.J. McCormick, L. Bibic, C. Bernadó Morales, J. Arribas, M. Canals, V. Casadó, E.I. Canela, M. Guzmán, E. Pérez-Gómez, C. Sánchez

Article / Heparin length in the coating of extremely small iron oxide nanoparticles regulates: In vivo theranostic applications

Nanoscale

Groult, H.; Carregal-Romero, S.; Castejón, D.; Azkargorta, M.; Miguel-Coello, A.B.; Pulagam, K.R.; Gómez-Vallejo, V.; Cousin, R.; Muñoz-Caffarel, M.; Lawrie, C.H.; Llop, J.; Piot, J.M.; Elortza, F.; Maugard, T.; Ruiz-Cabello, J.; Fruitier-Arnaudin, I.

Article / Pre-targeting with ultra-small nanoparticles: Boron carbon dots as drug candidates for boron neutron capture therapy

Journal of Materials Chemistry B

Feiner, I.V.J.; Pulagam, K.R.; Uribe, K.B.; Passannante, R.; Simó, C.; Zamacola, K.; Gómez-Vallejo, V.; Herrero-Álvarez, N.; Cossío, U.; Baz, Z.; Caffarel, M.M.; Lawrie, C.H.; Vugts, D.J.; Rejc, L.; Llop, J.

Review / The role of the il-6 cytokine family in epithelial–mesenchymal plasticity in cancer progression

International Journal of Molecular Sciences

Abaurrea, A.; Araujo, A.M.; Caffarel, M.M.

2020

Article / Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy

Particle and Particle Systems Characterization

Feiner, I.V.J.; Pulagam, K.R.; Gómez-Vallejo, V.; Zamacola, K.; Baz, Z.; Caffarel, M.M.; Lawrie, C.H.; Ruiz-de-Angulo, A.; Carril, M.; Llop, J.

2019

Article / Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer

Proceedings of the National Academy of Sciences of the United States of America

Blasco-Benito, S.; Moreno, E.; Seijo-Vila, M.; Tundidor, I.; Andradas, C.; Caffarel, M.M.; Caro-Villalobos, M.; Urigüen, L.; Diez-Alarcia, R.; Moreno-Bueno, G.; Hernández, L.; Manso, L.; Homar-Ruano, P.; McCormick, P.J.; Bibic, L.; Bernadó-Morales, C.; Arribas, J.; Canals, M.; Casadó, V.; Canela, E.I.; Guzmán, M.; Pérez-Gómez, E.; Sánchez, C.

2018

Article / Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases

F1000Research

Lawrie, C.H.; Goicoechea, I.; Rezola, R.; Arestin, M.; Caffarel, M.M.; Cortazar, A.R.; Manterola, L.; Fernandez-Mercado, M.; Armesto, M.; Sole, C.; Larrea, E.; Araujo, A.M.; Ancizar, N.; Plazaola, A.; Urruticoechea, A.; Carracedo, A.; Ruiz, I.; Alvarez Lopez, I.

Article / Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms

Journal of Molecular Diagnostics

Lawrie, C.H.; Armesto, M.; Fernandez-Mercado, M.; Arestín, M.; Manterola, L.; Goicoechea, I.; Larrea, E.; Caffarel, M.M.; Araujo, A.M.; Sole, C.; Sperga, M.; Alvarado-Cabrero, I.; Michal, M.; Hes, O.; López, J.I.

Article / Expression profiling analysis reveals key Microrna-mRNA interactions in early retinal degeneration in retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Anasagasti, A.; Ezquerra-Inchausti, M.; Barandika, O.; Culla, M.M.; Caffarel, M.M.; Otaegui, D.; López de Munain, A.; Ruiz-Ederra, J.

Article / Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma

Journal of Pathology

Kucia-Tran, J.A.; Tulkki, V.; Scarpini, C.G.; Smith, S.; Wallberg, M.; Paez-Ribes, M.; Araujo, A.M.; Botthoff, J.; Feeney, M.; Hughes, K.; Caffarel, M.M.; Coleman, N.

2016

Article / MicroRNA expression in B-cell lymphomas

MicroRNA

Carla Sole, Erika Larrea, Lorea Manterola, Ibai Goicoechea, Maria Armesto, Maria Arestin, Maria M Caffarel, Angela M Araujo, Marta Fernandez-Mercado, Maria Araiz, Charles H Lawrie

Article / Molecular Biology of Breast Cancer

eLS

Caffarel, Maria M ;Pensa, Sara ;Wickenden, Julie A ;Watson, Christine J

Article / Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival

British Journal of Cancer

Kucia-Tran, J.A.; Tulkki, V.; Smith, S.; Scarpini, C.G.; Hughes, K.; Araujo, A.M.; Yan, K.Y.M.; Botthof, J.; Pérez-Gómez, E.; Quintanilla, M.; Cuschieri, K.; Caffarel, M.M.; Coleman, N.

Review / New concepts in cancer biomarkers: Circulating miRNAs in liquid biopsies

International Journal of Molecular Sciences

Larrea, E.; Sole, C.; Manterola, L.; Goicoechea, I.; Armesto, M.; Arestin, M.; Caffarel, M.M.; Araujo, A.M.; Araiz, M.; Fernandez-Mercado, M.; Lawrie, C.H.

2015

Article / Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

J Natl Cancer Inst

E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel et al.

Article / Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer

Journal of the National Cancer Institute

Pérez-Gómez, E.; Andradas, C.; Blasco-Benito, S.; Caffarel, M.M.; García-Taboada, E.; Villa-Morales, M.; Moreno, E.; Hamann, S.; Martín-Villar, E.; Flores, J.M.; Wenners, A.; Alkatout, I.; Klapper, W.; Röcken, C.; Bronsert, P.; Stickeler, E.; Staebler, A.; Bauer, M.; Arnold, N.; Soriano, J.; Pérez-Martínez, M.; Megías, D.; Moreno-Bueno, G.; Ortega-Gutiérrez, S.; Artola, M.; Vázquez-Villa, H.; Quintanilla, M.; Fernández-Piqueras, J.; Canela, E.I.; McCormick, P.J.; Guzmán, M.; Sánchez, C.

Oncostatin M signalling in cancer-related inflammation: Implications in breast cancer and in hepatocellular carcinoma

UPV /EHU

Andrea Abaurrea Larrañaga - Finished

Targeting the Oncostatin M receptor to improve the treatment of squamous cell carcinomas

University of Cambridge

Justyna Kucia-Tran - Finished

2023

Nuevas alternativas terapéuticas para el cáncer de mama resistente a platinos

UPV/EHU

2022

Papel de la citoquina pro-inflamatoria Oncostatina M en el microambiente tumoral del cáncer de mama e implicación en inmunoterapia

UPV/EHU

2020

Role of extracellular vesicles in cytokine signalling and breast cancer metastasis

EHU/UPV

2019

Molecular characterisation of mammary tumours after OSMR depletion

UPV/EHU

2017

Optimisation of lentivirus-mediated depletion of Oncostatin M receptor in breast cancer cells

UPV / EHU

2016

Role of Oncostatin M receptor in the resistance to chemotherapy in breast cancer

EHU/UPV

2023

Identification of new therapeutic targets in breast cancer. Oncología Experimental. Máster Universitario en Investigación Biomédica. Facultad de Medicina Y Odontología (UPV/EHU). Coordinador Master y asignatura: Aintzane Asumendi Mallea

Reprogramación metabólica e hipoxia tumoral, Diploma de Especialización en Oncología Traslacional, ASEICA y Universidad Complutense de Madrid

2021

Role of inflammation in breast cancer. Workshop in Molecular Biology. Máster Universitario en Biología Molecular y Biomedicina, Facultad de Ciencia y Tecnología (UPV), Coordinadora de la asignatura: Ana Zubiaga (UPV), Coordinador del Master: Asier Fullaondo

2020

2019

Cytokine signalling in the tumour and stroma of breast cancer. Asignatura: "Casos prácticos: del laboratorio a la clínica", Máster Universitario en Terapias Avanzadas e Innovación Biotecnológica, Universidad Francisco de Vitoria, Madrid, España. Coordinadora asignatura: Cristina Sánchez Martínez

2018

Cannabinoids as antitumoural therapy. Workshop in Molecular Biology. Máster Universitario en Biología Molecular y Biomedicina, Facultad de Ciencia y Tecnología (UPV/EHU), Coordinadora de la asignatura: Ana Zubiaga, Coordinador del Master: Asier Fullaondo

2017

Cannabinoids as antitumoural therapy. Workshop in Molecular Biology. Máster Universitario en Biología Molecular y Biomedicina, Facultad de Ciencia y Tecnología (UPV), Coordinadora de la asignatura: Ana Zubiaga (UPV), Coordinador del Master: Asier Fullaondo

Identification of new therapeutic targets in breast cancer. Oncología Experimental. Máster Universitario en Investigación Biomédica. Facultad de Medicina Y Odontología (UPV). Coordinador Master y asignatura: Aintzane Asumendi Mallea (UPV)

2016

Identification of drug resistance mechanisms in breast cancer. Oncología Experimental. Máster Universitario en Investigación Biomédica. Facultad de Medicina Y Odontología (UPV). Coordinador Master y asignatura: Aintzane Asumendi Mallea (UPV)

Identification of new therapeutic targets in breast cancer. Bases moleculares de la Proliferación, Diferenciación y Muerte Celular. Máster Universitario en Biología Molecular y Biomedicina, Facultad de Ciencia y Tecnología (UPV), Coordinador de la asignatura: Jose Antonio Rodriguez, Coordinador del Master: Asier Fullaondo

2023

Member of the Cancer Panel evaluating National Grants for Instituto de Salud Carlos III (ISCIII)

Founding member of European Association for Cancer Research (EACR) Early Career Researchers’s council - since 2023

2022

Member of the Cancer Panel evaluating National Grants for Instituto de Salud Carlos III (ISCIII), 2022

Member of the European Association of Cancer research (EACR) Review Panel - since 2022

2021

Member of the panel evaluator for Juan de la Cierva programme, Spanish National Research Agency (AEI)

President of the Animal Research Ethics Committee (CEEA) of Biodonostia Health Research Institute

2020

Member of the panel evaluator for Ramon y Cajal programme, Spanish National Research Agency (AEI)

2019

Member of the Board of Trustees at ASEICA (Asociación Española de Investigación sobre el Cáncer).

Member of the Animal Research Ethics Committee (CEEA) of Biodonostia Health Research Institute

President of the Gender Equality Committee of Biodonostia Health Research Institute

Coordinator or ASEICA-Young group within ASEICA (Asociación Española de Investigación sobre el Cáncer)

Member of the Responsible Research and Innovation (RRI) Committee at Biodonostia Health Research Institute

Member of the Innovation Support Unit (UAI, Unidad de Apoyo a la Investigacion) at Biodonostia Health Research Institute

2017

Miembro del Comité de Tumores de Mama del Hospital Donostia

Miembro de la Unidad Funcional de Mama de Onkologikoa

2022

Premio con Nombre de Mujer, Fundacion Merck Salud- Asociación Española de Investigación en Cáncer (ASEICA), 2022

Elected founding member of European Association for Cancer Research (EACR) Early Career Researchers’s council, 2022.

2021

Member of TransGEICAM (Translational research Group) at GEICAM (Spanish Breast Cancer Group

Prize to the best Oral Communication in the 1ST INTERNATIONAL CONFERENCE ON NANOMEDICINE MEETS THE TUMOR MICROENVIRONMENT (online International Conference) to the PhD student of my group Andrea Abaurrea

2019

Prize to the best Oral Communication in the 1st International Symposium ASEICA-ASPIC Conference (Salamanca, Spain) to the PhD student of my group Angela Araujo

Prize to the best Oral Communication in the 2nd ASEICA Educational Symposium (Madrid, Spain) to the PhD student of my group Angela Araujo

Prize to the best Poster Presentation in the Conference "Seed and Soil: Mechanisms of Metastasis" (Berlin, Germany) to phD student of my group Angela Araujo

2017

Second Prize to the best oral Communication in the 11th International Symposium of GEICAM, Zaragoza, 2017

Award to the best Oral Communication (11th Symposium GEICAM, 2017, Zaragoza, Spain)

2023

Conference organization | 18th INTERNATIONAL CONGRESS of the Spanish Association for Cancer Research (ASEICA),

Maria M Caffarel

Conference organization | Scientific and Organizing Committee, 3rd EACR Early Career Researchers' Conference

Maria M Caffarel

2022

Invited talk | New avenues for breast cacner immunotherapy

Australia-Spain mini-symposium on breast cancer - Invited talk

Maria M Caffarel

Invited talk | Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment

Maria M Caffarel

Invited talk | The pro-inflammatory cytokine Oncostatin M promotes cancer progression by reprograming the tumor microenvironment

Maria M Caffarel

Invited talk | promoting women in science, networking and peer mentoring - experiences from ASEICA young

Early Career Researchers Conference, European Association for Cancer Research - Invited talk

Maria M Caffarel, Veronica Torrano, Toni Celia-Terrassa

Oral presentation | Stromal Oncostatin M cytokine signalling promotes breast cancer progression and metastasis by reprogramming the tumour microenvironment

EMBO | EMBL Symposium: Defining and defeating metastasis - Oral presentation

Maria M Caffarel

2021

Conference organization | 17th ASEICA International Congress 2020

17th ASEICA International Congress - Conference organization

Maria M Caffarel

Invited talk | tromal Oncostatin M axis promotes breast cancer progression and tumour‐promoting inflammation

2nd International HCSC-Simposium on Traslational Cancer Resarch - Invited talk

Maria M Caffarel

Invited talk | Stromal Oncostatin M axis promotes breast cancer progression and tumour‐promoting inflammation

2021 CERFA Cancer Symposium - Invited talk

Maria M Caffarel

Invited talk | The role of the cytokine Oncostatin M in inflammation and disease

Biomedical Science Research and Training Centre (BioRTC) Launch Symposium - Invited talk

Maria M Caffarel

2020

Invited talk | Importancia del microambiente inmune tumoral y diseño de dianas terapéuticas

Conclusiones GEICAM del 42nd SABCS - Invited talk

Maria M Caffarel

2019

Conference organization | Scientific coordinator

2nd ASEICA Educational Symposium - Conference organization

Maria M Caffarel

Conference organization | Chairman of poster session

1.ª Reunión de Hepatología Traslacional, Status Quo y nuevos horizontes en el estudio del hígado - Conference organization

Maria M Caffarel

Invited talk | Avances en el conocimiento biológico del cáncer de mama

Revisión Anual GEICAM en Cáncer de Mama (RAGMA) - Invited talk

Maria M Caffarel

Invited talk | Activation of Cancer Associated Fibroblasts by the pro-inflammatory cytokine OSM contributes to breast cancer progression

1st Cancer Research Networking Day - Invited talk

Angela Araujo; Andrea Abaurrea; Ricardo Rezola; Paloma Bragado; Arkaitz Carracedo; Fernando Calvo; Nicholas Coleman; Clare Isacke; Charles H Lawrie; Maria M Caffarel

Invited talk | Oncostatin M released by immune cells in the tumour microenvironment activates cancer cells and fibroblasts to promote breast cancer progression

Annual Workshop of Young Researchers of CIC biomaGUNE - Invited talk

Maria M Caffarel

Oral presentation | Activation of cancer associated fibroblasts by oncostatin M contributes to breast cancer progression

2nd ASEICA Educational Symposium - Oral presentation

Angela Araujo; Andrea Abaurrea; Joanna Lopez; Iñaki Osorio; Charles H Lawrie; Maria M Caffarel

Oral presentation | The inflammatory cytokine oncostatin M promotes breast cancer progression

2nd ASEICA Educational Symposium - Oral presentation

Andrea Abaurrea; Angela Araujo; Joanna Lopez; Iñaki Osorio; Ander Urruticoechea; Isabel Álvarez-López; Charles H Lawrie; Maria M Caffarel

Oral presentation | Oncostatin M released by myeloid cells in the tumour microenvironment activates cancer cells and fibroblasts to promote breast cancer progression

ASEICA-ASPIC INTERNATIONAL MEETING "Current Trends in Immunotherapy Research and Treatment" - Oral presentation

Angela Araujo; Joanna Lopez; Andrea Abaurrea; Charles H Lawrie; Maria M Caffarel

Oral presentation | New targets for metastatic Breast Cancer: Role of the pro-inflammatory cytokine Oncostatin M

42 Congreso de la SEBBM - Oral presentation

Angela Araujo; Andrea Abaurrea; Ricardo Rezola; Paloma Bragado; Arkaitz Carracedo; Fernando Calvo; Nicholas Coleman; Clare Isacke; Charles H Lawrie; Maria M Caffarel.

Oral presentation | CHARACTERIZATION OF THE AGE-ASSOCIATED DERMAL STEM CELL DYSFUNCTION

International Conference on Skin Ageing & Challenges - Oral presentation

A Izeta; L Yndriago; L GARDEAZABAL; V PEREZ-LOPEZ; I PRIETO; A ABAURREA; MM CAFFAREL

Poster presentation | Role of the pro-inflammatory cytokine Oncostatin M in breast cancer metastasis

Seed and Soil: Mechanisms of Metastasis - Poster presentation

Angela Araujo; Andrea Abaurrea; Ricardo Rezola; Paloma Bragado; Arkaitz Carracedo; Fernando Calvo; Nicholas Coleman; Clare Isacke; Charles H Lawrie; Maria M Caffarel

Poster presentation | The pro-inflammatory cytokine OSM contributes to breast cancer progression by activating OSMR in both the cancer and the stromal compartment

3rd International Conference on Cytokine Signaling in Cancer - Poster presentation

Angela Araujo; Andrea Abaurrea; Ricardo Rezola; Paloma Bragado; Arkaitz Carracedo; Fernando Calvo; Nicholas Coleman; Clare Isacke; Charles H Lawrie; Maria M Caffarel

Poster presentation | The pro-inflammatory cytokine OSM contributes to breast cancer progression by activating the tumour microenvironment

31st International Association for Breast Cancer Research Conference - Poster presentation

Angela Araujo; Andrea Abaurrea; Ricardo Rezola; Paloma Bragado; Arkaitz Carracedo; Fernando Calvo; Nicholas Coleman; Clare Isacke; Charles H Lawrie; Maria M Caffarel

Poster presentation | A pretargeting strategy based on bioorthogonal ‘click reaction’ for multifunctionalized gold nanoparticles (GNPs) as boron drug delivery agents with application in Boron Neutron Capture Therapy (BNCT)

14th European Molecular Imaging Meeting - Poster presentation

I Feiner; K Reddy Pulagama; A Ruiz de Angulo; K Zamacola; MM CAFFAREL; CH Lawrie; V Gómez-Vallejo; J Llop

2018

Conference organization | Invited chair of scientific session

16th ASEICA INTERNATIONAL CONGRESS - Conference organization

Maria M Caffarel

Oral presentation | Dissecting the interactions between the tumour microenvironment and Oncostatin M pathway to find new therapeutic targets in advanced breast cancer

3rd Emerging Scientist Workshop of the SEBBM - Oral presentation

Angela Araujo; Andrea Abaurrea; Paloma Bragado; Arkaitz Carracedo; Clare Isacke; Charles H Lawrie; Maria M Caffarel

Poster presentation | ROLE OF FATTY ACID AMIDE HYDROLASE (FAAH) IN BREAST DEVELOPMENT AND CANCER

EACR25: 25th Biennial Congress of the European Association for Cancer Research - Poster presentation

I Tundidor; S Blasco-Benito; M Seijo-Vila; M Caro-Villalobos; MM Caffarel; G Moreno-Bueno; M Guzmán; C Sánchez; E Perez-Gomez

Poster presentation | Oncostatin M Signalling mediates the crosstalk between cancer cells and tumour microenvironment and promotes breast cancer progression

EACR25: 25th Biennial Congress of the European Association for Cancer Research - Poster presentation

Angela Araujo; Andrea Abaurrea; Charles H Lawrie; Maria M Caffarel

Poster presentation | New targets in Triple Negative Breast Cancer: Role of Oncostatin M receptor pathway

EACR25: 25th Biennial Congress of the European Association for Cancer Research - Poster presentation

Andrea Abaurrea; Angela Araujo; Rezola R; Ander Urruticoeachea; Isabel Alvarez-Lopez; Charles H Lawrie; Maria M Caffarel

Poster presentation | Estudio del receptor de Oncostatina M como nueva diana terapéutica en cáncer de mama Triple Negativo (TNBC) (Selected as highlighted poster)

SEOM2018 - Poster presentation

Maria M Caffarel; Angela Araujo; Andrea Abaurrea; Rezola R; Ander Urruticoechea; Charles H Lawrie; Isabel Alvarez-Lopez

Poster presentation | The pro-inflammatory cytokine OSM contributes to breast cancer progression by activating the tumour microenvironment

16th ASEICA INTERNATIONAL CONGRESS - Poster presentation

Angela Araujo; Andrea Abaurrea; Clare Isacke; Paloma Bragado; Fernando Calvo; Charles H Lawrie; Maria M Caffarel

Poster presentation | New targets in triple negative breast cancer: Role of Oncostatin M receptor pathway

2018 San Antonio Breast Cancer Symposium (SABCS) - Poster presentation

Isabel Alvarez-Lopez; Angela Araujo; Andrea Abaurrea; Rezola R; Ander Urruticoechea; Charles H Lawrie; Maria M Caffarel

2017

Invited talk | Cannabinoids, a new hope for cancer therapy?

ATHS 13th International Congress - Invited talk

Maria M Caffarel

Oral presentation | ONCOSTATIN M RECEPTOR IS A NOVEL THERAPEUTIC TARGET IN TRIPLE NEGATIVE BREAST CANCER

11th International Symposium GEICAM (2nd prize best oral communication) - Oral presentation

Maria M Caffarel; Angela Araujo; Charles H Lawrie; Isabel Alvarez-Lopez

Oral presentation | New targets in Triple Negative Breast Cancer: Role of Oncostatin M receptor pathway

ESMO 2017 Congress - Oral presentation

Maria M Caffarel; Angela Araujo; Ricardo Rezola; Charles H Lawrie; Isabel Alvarez-Lopez

Poster presentation | Dissecting the interactions between the tumour microenvironment and Oncostatin M receptor pathway to find new therapeutic targets in Triple Negative breast cancer

Tumour Microenvironment - Basic Science to Novel Therapies - Poster presentation

Angela Araujo; Oscar M Rueda; Paloma Bragado; Nicholas Coleman; Charles H Lawrie; Maria M Caffarel

Poster presentation | Oncostatin M receptor is a novel therapeutic target in Triple Negative Breast Cancer

FEBS Advance Lecture Course on Molecular Mechanisms in Signal Transduction and Cancer - Poster presentation

Angela Araujo; Charles H Lawrie; Maria M Caffarel

Poster presentation | New targets in Triple Negative Breast Cancer: Role of Oncostatin M receptor pathway

1st ASEICA EDUCATIONAL SYMPOSIUM - Poster presentation

Caffarel, Maria M; Araujo, Angela; Abaurrea, Andrea; Rezola R; Alvarez-Lopez, Isabel; Lawrie, Charles H

2016

Poster presentation | Dissecting the interactions between the tumour microenvironment and Oncostatin M receptor pathway to find new therapeutic targets on Triple Negative breast cancer

EMBO - EMBL Symposium: Tumour Microenvironment and Signalling - Poster presentation

Angela M Araujo, Charles H Lawrie, Maria M Caffarel

Poster presentation | Oncostatin M receptor is a novel therapeutic target in Triple Negative Breast Cancer

MAP 2016 Molecular Analysis for Personalised Therapy - Poster presentation

Angela Araujo; Charles H Lawrie; Maria M Caffarel

Poster presentation | Overexpression of the Oncostatin M Receptor in Cervical Squamous Cell Carcinoma Cells induces Multiple Pro-malignant Effects in vitro and in vivo

ISREC-SCCL Horizons of Cancer Biology and Therapy - Poster presentation

Valtteri Tulkki ;Justyna Kucia-Tran ;Paez-Ribes, Marta ;Valeria Radjabova ;Maria M Caffarel ;Nick Coleman

2015

Invited talk | Cannabinoids as antitumoral therapy: the way from bench to bedside

4eme Conference Internationale UFCM-I Care - Invited talk

Maria M Caffarel

Oral presentation | Oncostatin M receptor over-expression has strong pro-malignant effects in cervical squamous cell carcinoma

FEBS Advance Lecture Course on Molecular Mechanisms in Signal Transduction and Cancer - Oral presentation

Justyna Kucia ;Valtteri Tulkki ;Cinzia G Scarpini ;Paez-Ribes, Marta ;Maria M Caffarel ;Nick Coleman

Poster presentation | OVER-EXPRESSION OF THE ONCOSTATIN M RECEPTOR IN SQUAMOUS CELL CARCINOMA ASSOCIATES WITH INDUCTION OF EMT AND METASTASIS

Metastasis initiation - mechanistic insights and therapeutic opportunities - Poster presentation

Maria M Caffarel, Justyna Kucia, Valtteri Tulkki, Angela Araujo and Nick Coleman

Poster presentation | THE ONCOSTATIN M RECEPTOR IS A NOVEL THERAPEUTIC TARGET IN SQUAMOUS CELL CARCINOMA

15th Aseica International Congress - Poster presentation

Maria M Caffarel, Justyna Kucia, Valtteri Tulkki, Angela Araujo and Nick Coleman

Poster presentation | Oncostatin M receptor over-expression has strong pro-malignant effects in cervical squamous cell carcinoma

2nd AstraZeneca-MedImmune Cambridge Cancer Science Symposium - Poster presentation

Justyna Kucia ;Valtteri Tulkki ;Cinzia G Scarpini ;Paez-Ribes, Marta ;Maria M Caffarel ;Nick Coleman

Poster presentation | The Role of Oncostatin M Receptor Over-Expression in Tumour Microenvironment of Cervical Squamous Cell Carcinoma

7th International Conference on Tumour Microenvironment: Progression, Therapy & Prevention - Poster presentation

Valtteri Tulkki ;Justyna Kucia ;Cinzia G Scarpini ;Maria M Caffarel ;Nick Coleman